FABA BIOTECHNOLOGY

SHANTHA BIOTECHNICS

Shantha Biotechnics is a Biotechnology Pioneer from the developing world. Founded in 1993 by Dr. K I Varaprasad Reddy in Hyderabad, India, today Shantha is a fully integrated Biotechnology company involved in R&D, Manufacturing & Marketing.

Shantha’s mission is to develop, produce and market human health care products which are affordable and meet the highest International Standards. Shantha launched India's first genetically engineered product SHANVAC-B- rDNA Hepatitis-B Vaccine in August, 1997 which has WHO Pre Qualification Approval and is being sold to more than 50 countries across the globe and meets a major part of UNICEF’s requirement for Hepatitis-B vaccine.

Shantha’s R&D team is focused on Vaccines and Biotherapeutics and has developed products like Shanferon – r-Interferon Alfa 2b; Shanpoetin- r-Erythropoetin and Shantetra- DTP-Hep-B Combi Vaccine. Shantha has created State of Art Manufacturing facilities to cater to global scale requirements.

The current R&D focus is on Vaccines, Biotherapeutics, Diagnostics and Monoclonal Antibodies and Shantha has an exciting pipeline of products and technologies in these segments. Shantha West Inc., USA, a subsidiary of Shantha, is involved in the development of novel therapeutic monoclonal antibodies for the treatment of different types of Cancer.

Shantha is committed to the enhancement and preservation of its Intellectual Property and respects the Intellectual Property rights of others. Shantha holds various International Patents including Product Patent for Monoclonal Antibodies like TB-94 in US and process patents for Shanferon. Shantha with its strengths in R&D & manufacturing offers Contract Research & Manufacturing services to its clients.

Shantha is a recipient of various prestigious awards including the National Technology Awards for R&D excellence and the Conferment of the prestigious Civilian Honor “Padma Bhushan” upon Dr. Varaprasad Reddy by Hon’ble President of India.

www.shanthabiotech.com

BIOGRAPHY OF DR. VARAPRASAD REDDY

Varaprasad Reddy

Dr. Varaprasad Reddy is the harbinger of bio-pharma industry to India who could bring next-generation biotech products within the reach of common man by adhering to ‘Swadeshi' doctrine.

Born on November 17, 1948, Dr. Varaprasad Reddy started his career as Research Scientist in Defence Labs after graduating in Electronics Engineering from Andhra University and while serving A.P. Industrial Development Corpn., he assisted many entrepreneurs in promoting number of projects. In 1985 he left government service to become an entrepreneur himself. He co-promoted Sabnife Power Systems Ltd., an Indo Swedish joint venture for development and production of High Technology based batteries for Defence applications.

In 1992 he went tangential from his academic training and previous experience to step into biotechnology, a sunrise industry in India. He was fired by the enthusiasm of developing recombinant based therapeutic proteins for human healthcare. He believed that by adopting ‘Swadeshi' principle, one could produce most efficacious yet cost-effective vaccines and drugs to reach out to common man.

Shantha Biotechnics Ltd., the company he has promoted and heads could bring out India’s first genetically engineered product Shanvac-B, a vaccine against dreaded infection Hepatitis-B that affects nearly 5% Indian population. This ‘swadeshi’ product, developed thru in-house R&D efforts, proved to be highly efficacious, did India proud by reaching market at an affordable price, just a fraction of the imported vaccine price in the 50th of year of independence.

Apart from several National and International awards both Shantha Biotechnics and Dr. Varaprasad Reddy have won, Government of India has conferred the prestigious National Award “PADMA BHUSHAN” to Dr. Varaprasad Reddy by Hon’ble President of India in the year 2005. He loves music and literature and was felicitated by many local literary, cultural organisations and Non-resident Telugu association abroad.